Assignment of Assignor's Interest

Recorded: 2014-05-20 Pages: 4

View PDF Order Certified Copy

Assignors

HAGEN, ERIC J.

Executed: 2005-03-25

HALLORAN, KEVIN

Executed: 2005-03-17

Assignee

DOV PHARMACEUTICAL, INC.

433 HACKENSACK AVENUE, HACKENSACK, NEW JERSEY, 07601

Covered Properties (6)

Novel polymorphs of azabicyclohexane

Application: 11/205,956 →

Publication: US 2007/0043100

Novel Polymorphs of Azabicyclohexane

Application: 12/208,284 →

Novel Polymorphs of Azabicyclohexane

Application: 12/428,399 →

Publication: US 2009/0326245

Novel Polymorphs Of Azabicyclohexane

Application: 13/207,144 →

Publication: US 2011/0294847

Novel Polymorphs Of Azabicyclohexane

Patent: 8,765,801 →

Application: 13/366,209 →

Publication: US 2012/0136038

Novel Polymorphs of Azabicyclohexane

Patent: 9,139,521 →

Application: 13/907,809 →

Publication: US 2013/0345279

Related Assignments (5)

Other recorded transfers of the patents in this record — the chain of ownership.

Merger Dec 29, 2011

From: DOV PHARMACEUTICAL, INC.

To: EUTHYMICS BIOSCIENCE, INC.

Reel/Frame 027457/0641 →

Assignment of Assignor's Interest Feb 20, 2014

From: HAGEN, ERIC J.; HALLORAN, KEVIN

To: DOV PHARMACEUTICAL, INC.

Reel/Frame 032260/0388 →

Change of Name Feb 20, 2014

From: DOV PHARMACEUTICAL, INC.

To: EUTHYMICS BIOSCIENCE, INC.

Reel/Frame 032260/0504 →

Assignment of Assignor's Interest May 20, 2014

From: HAGEN, ERIC J.; HALLORAN, KEVIN

To: EUTHYMICS BIOSCIENCE, INC.

Reel/Frame 032934/0157 →

Assignment of Assignor's Interest Feb 5, 2018

From: EUTHYMICS BIOSCIENCE, INC.

To: ETHISMOS RESEARCH, INC.

Reel/Frame 045252/0870 →